PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

PB2342: PROGNOSTIC SIGNIFICANCE OF PRETREATMENT NEUTROPHIL/LYMPHOCYTE RATIO, PLATELET/LYMPHOCYTE RATIO AND SYSTEMIC IMMUNE-INFLAMMATION INDEX IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

Bibliografski detalji
Glavni autori:	Ons Charef, Zaineb Mlayah, Yasmine Bnouni, Nada Mabrouk, Wiem Boufrikha, Slama Nader, Sarra Boukhriss, Adnene Laatiri
Format:	Članak
Jezik:	English
Izdano:	Wiley 2023-08-01
Serija:	HemaSphere
Online pristup:	http://journals.lww.com/10.1097/01.HS9.0000976088.62089.d8

Slični predmeti

PB2284: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECT OF INDOLENT LYMPHOMAS IN TUNISIA
od: Ons Charef, i dr.
Izdano: (2023-08-01)

PB2631: CLINICAL FEATURES, TREATMENTS AND OUTCOMES OF PRIMARY IMMUNE THROMBOCYTOPENIA IN ADULTS: A SINGLE CENTER RETROSPECTIVE STUDY FROM TUNISIA.
od: Yasmine Bnouni, i dr.
Izdano: (2023-08-01)

PB1982: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF CHRONIC MYELOID LEUKEMIA: EXPERIENCE OF FATTOUMA BOURGUIBA HOSPITAL OF MONASTIR
od: Sana Lakhel, i dr.
Izdano: (2023-08-01)

PB2160: MULTIPLE MYELOMA IN THE ELDERLY: A MONOCENTRIC EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF MONASTIR (TUNISIA)
od: Bizid Inaam, i dr.
Izdano: (2023-08-01)

A descriptive study of patients with myelodysplastic syndrome: experience of the clinical hematology department of Monastir-Tunisia
od: Arij Cheffai, i dr.
Izdano: (2023-01-01)

PB2563: IRON DEFICIENCY ANEMIA: A MONOCENTRIC EXPERIENCE OF THE HAEMATOLOGY DEPARTMENT OF MONASTIR, TUNISIA
od: Donia Bouhoula, i dr.
Izdano: (2023-08-01)

PB2354: DIFFUSE LARGE B CELL LYMPHOMA IN 65: DIAGNOSTIC, PROGNOSTIC, PROGRESSIVE AND THERAPEUTIC ASPECTS
od: Zaineb Mlayah, i dr.
Izdano: (2023-08-01)

PB1834: ACQUIRED FACTOR VII DEFICIENCY ASSOCIATED WITH ACUTE MYELOID LEUKEMIA
od: Haifa Hafsa, i dr.
Izdano: (2023-08-01)

Polycythemia Vera and associated risk factors
od: Ben Salem Sirine, i dr.
Izdano: (2023-01-01)

PB2296: THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN COVID-19 PATIENTS: A MONOCENTRIC STUDY
od: W. Boufrikha, i dr.
Izdano: (2022-06-01)

PB2250: THE IMPACT OF JAK2V617F MUTATION POSITIVITY IN ESSENTIAL THROMBOCYTHEMIA:ABOUT 74 CASES.
od: Arij Cheffai, i dr.
Izdano: (2023-08-01)

PB2241: THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES
od: Arij Cheffai, i dr.
Izdano: (2023-08-01)

Very late relapse of Burkitt's lymphoma in an EBV-negative patient after 20 years of complete remission
od: Kmar Mrad, i dr.
Izdano: (2024-01-01)

PB1964: COMPARISON OF CLINICO-HEMATOLOGICAL PARAMETERS AND MOLECULAR AND CYTOGENETIC RESPONSE OF TWO BCR-ABL FUSION TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB
od: Laabidi Baraa, i dr.
Izdano: (2023-08-01)

Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival
od: Baraa Laabidi, i dr.
Izdano: (2023-01-01)

The Impact of the Inflammatory Ratios Neutrophil To Lymphocyte Ratio, Monocyte To Lymphocyte Ratio, Platelet To Lymphocyte Ratio on Abdominal Aortic Aneurysm Growth
od: M. Stevanov, i dr.
Izdano: (2024-01-01)

Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of refractory anaphylaxis
od: Le Vinh Nghi, MD, i dr.
Izdano: (2024-08-01)

The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio and delirium in ischemic stroke patients
od: Pangbo Wang, i dr.
Izdano: (2025-01-01)

Difference of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Non-Hodgkin and Hodgkin Lymphoma
od: Frenky Jones, i dr.
Izdano: (2024-12-01)

Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) in Pituitary Adenomas
od: Alberto C. Nesello, i dr.
Izdano: (2025-01-01)

Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in the Patients with Euthyroid Hashimoto's Thyroiditis
od: Hacer Nur RESBER, i dr.
Izdano: (2023-09-01)

Correlation Of Neutrophil Lymphocyte Ratio And Platelet Lymphocyte Ratio With Severity Of COVID-19
od: Fadil Ahmadhia Warman, i dr.
Izdano: (2024-07-01)

Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Branch Retinal Vein Occlusion
od: Dan-dan Zhu, i dr.
Izdano: (2019-01-01)

Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Crohn’s Disease
od: Jue-Rong Feng, i dr.
Izdano: (2017-01-01)

Predictive role of platelets to lymphocytes ratio and neutrophil to lymphocytes ratio in COPD exacerbation
od: Hussien Fayiad, i dr.
Izdano: (2024-07-01)

The Role of Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) in Appendicitis
od: Moch Junaidy Heriyanto, i dr.
Izdano: (2023-10-01)

Increased Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Chronic and Severe Urticaria
od: Sarah Weissmann, i dr.
Izdano: (2024-04-01)

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in depressed patients with suicidal behavior: A systematic review
od: A Velasco, i dr.
Izdano: (2024-01-01)

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study
od: Sümeyre Seda Ertekin, i dr.
Izdano: (2024-04-01)

Clonal eosinophilia with exclusive pulmonary involvement driven by PDGFRA rearrangement treated with imatinib: A case report
od: Zaineb Mlayah, i dr.
Izdano: (2025-01-01)

The prognostic value of pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with esophageal cancer undergoing immunotherapy: a systematic review and meta-analysis
od: Min Deng, i dr.
Izdano: (2025-02-01)

Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study
od: Dong Yang, i dr.
Izdano: (2024-04-01)

Insights into Philadelphia Chromosome-Positive ALL: A Retrospective Study
od: Zaouali Dridi Aya, i dr.
Izdano: (2023-01-01)

The Prognosis of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Elderly with Acute Ischemic Stroke
od: Wang J, i dr.
Izdano: (2024-10-01)

Prognostic Value of Neutrophils-to-Lymphocytes Ratio and Platelets-to-Lymphocytes Ratio in Sepsis Patients With Lymphopenia
od: Xianming Qiu, i dr.
Izdano: (2024-01-01)

The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson’s disease
od: Fangyi Li, i dr.
Izdano: (2024-01-01)

To Quantify the Prognostic Impact of Pretreatment Neutrophil Lymphocyte Ratio (NLR) on Head and Neck Cancer
od: Rekha S Vashisth, i dr.
Izdano: (2024-10-01)

Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
od: Liao QQ, i dr.
Izdano: (2024-02-01)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis
od: Ye, JH, i dr.
Izdano: (2024)

Systematic review and meta-analysis of the association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with periodontitis
od: Saeideh Ghasemi, i dr.
Izdano: (2024-12-01)